
About this compound
Tesamorelin is a synthetic analogue of the complete 44-residue human GHRH sequence, modified with a trans-3-hexenoyl group at the N-terminus.
Studied in
- GH/IGF-1 axis
- Adipose distribution models
- Endocrine signalling
Compound identity
| Compound | Tesamorelin |
|---|---|
| CAS number | 901758-09-6 |
| Molecular formula | C221H366N72O67S |
| Molecular weight | 5,135.9 Da |
Specifications
- Purity method: HPLC
- Appearance: Lyophilized powder
- Solubility: Reconstitute per protocol; see Supplies for diluents.
- We don't publish a purity percentage here — that figure is only meaningful tied to the lot you actually receive, so it lives on the lot certificate.
Endocrine
VERDICT
Tesamorelin
Stabilised GHRH analog, studied in metabolic-endocrine research.
What the research targets
Studied as a stabilised GHRH analog in GH-axis research, including adipose-tissue distribution models.
Supply formats
Single units ship from stock. Cases are back-ordered against the same single-unit price.
Stick is newly released — available alongside the vial on every compound.
Single unit
Sample quantity — one unit.
10 mgVial
PS-9789916-10-MG
On verified accountSkinni Stick™ 10 mgSkinni Stick™New
Single-compound Skinni Stick™. Supplied to verified accounts only.
PS-9789916-PEN-10-MG
On verified account
Case — back-order
Ten of one size, at 10× volume pricing.
Case · 10 × 10 mg
Back-order — 15% off the single-unit price.
PS-9789916-C10-10-MG
On verified accountCase · 10 × Skinni Stick™ 10 mgNew
Back-order — 15% off the single-unit price.
PS-9789916-C10-PEN-10-MG
On verified account
One-time verification of professional or institutional affiliation. No payment is taken on this site.
Research use only
This compound is supplied exclusively for laboratory research by qualified professionals and institutions. It is not a drug, dietary supplement, or cosmetic, and is not for human or veterinary use. We publish no dosing, administration, or human-use guidance of any kind, and nothing here should be read as a claim about an effect in people.
From the research library
Cited summaries of the published work behind Tesamorelin — what was studied, in which model, and what was measured.
More in Endocrine

LONGWAVE
CJC-1295 (DAC)
Studied for its extended half-life relative to the no-DAC form in GH-axis research models.

DUET
CJC-1295 + Ipamorelin
Supplied as a single reconstitution for protocols that study a GHRH analog alongside a selective secretagogue.

PULSE
CJC-1295 (no DAC)
Studied for its short-acting pulsatile profile on the GH/IGF-1 axis in endocrine research models.
